ArticleCureus2025
Autoimmune Adrenalitis in Systemic Lupus Erythematosus: Identifying a Rare Endocrine Complication.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary adrenal insufficiency (PAI) secondary to nonhemorrhagic adrenalitis is an extremely rare but potentially life-threatening endocrine manifestation in patients with systemic lupus erythematosus (SLE). We report the case of a 51-year-old man with longstanding SLE and antiphospholipid syndrome (APS) who presented with an adrenal crisis, characterized by fatigue, weight loss, vomiting, and abdominal pain. Laboratory evaluation revealed hypotension, metabolic acidosis, elevated adrenocorticotropic hormone (ACTH), and low serum cortisol, confirming the diagnosis of PAI. Abdominal CT imaging demonstrated bilateral adrenal gland enlargement with periadrenal fat stranding, consistent with nonhemorrhagic adrenalitis. The patient showed rapid clinical improvement following initiation of stress-dose corticosteroids and was subsequently discharged on lifelong glucocorticoid and mineralocorticoid replacement therapy. This case emphasizes the importance of maintaining a high clinical suspicion for adrenal insufficiency in patients with SLE who present with nonspecific symptoms, such as fatigue, vomiting, and abdominal pain, that may be mistakenly attributed to a typical lupus flare, even when classic signs of adrenal hemorrhage or typical laboratory abnormalities are absent. Early diagnosis and treatment are critical to prevent life-threatening adrenal crises in this patient population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.